JP Morgan Raises Price Target to $43 for Aetna (AET)

JP Morgan has just increased the price target for Aetna AET from $38 to $43. The report notes, “this past Friday AET reported 4Q (EPS at $0.63 vs our $0.60), and like others this season, the med cost ratio coming in much better/lower while the bottom-line impact mitigated by higher G&A spend (some pull forward) holding down the EPS print.” JP Morgan believes Aetna's 2011 pricing and earnings outlook assumes “that cost trend rises to 8%+/-50bps, and this in line with what we are seeing across the sector. For insured business of course it's all about spread and the message consistent: if med cost trend doesn't rise, there's going to be some decent earnings upside.” JP Morgan maintained its Overweight rating while upgrading the price target to $43. Aetna closed at $36.87 on Monday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorPrice TargetAnalyst RatingsAetnaHealth CareJP MorganManaged Health Care
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!